Mara P. Steinkamp

This study shows auranofin enhances cisplatin response in endometrial cancer by modulating NOTCH signaling, with context-dependent effects on tumor models.

This study shows that organoids derived from patient-derived xenografts (PDXOs) reflect the chemotherapy response of ovarian cancer patients similarly to organoids directly from primary tumors (PDOs).

This study shows that M2 macrophages in the tumor microenvironment enhance ovarian cancer growth and reduce sensitivity to paclitaxel, and that targeting TAMs with CSF-1R inhibitors can improve treatment outcomes when combined with chemotherapy.